Next Generation Sequencing test with coverage of >170 variants in 17 genes frequently mutated in cancer, and includes EGFR T790M and EGFR C797S variant detection for drug resistance monitoring. Turnaround time of 5-7 business days from the laboratory’s receipt of specimen, which is faster than standard protocols including reflexive FISH and immunohistochemistry testing. Includes microsatellite instability (MSI) status for possible selection of anti-PD1 therapy.

[ 17 Genes ]

LiquidGx™ NGS Gene List: